Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis-Reference-Cited by-同舟云学术

Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis

Published:2015-04 Issue:3 Volume:30 Page:132-138
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Ozkan Zeynep Gozde¹,Poyanli Arzu²,Ucar Adem²,Kuyumcu Serkan¹,Akyuz Filiz³,Keskin Serkan⁴,Saglam Sezer⁵,Yilmaz Ebru¹,Karaca Cetin³,Turkmen Cuneyt¹

Affiliation:

1. Nuclear Medicine Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

2. Interventional Radiology Unit, Radiodiagnostic Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

3. Gastroenterology and Hepatology Unit, Internal Medicine Department, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.

4. Medical Oncology Department, Institute of Oncology, Istanbul University, Istanbul, Turkey.

5. Medical Oncology Department, Medical Faculty, Bilim University, Istanbul, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2014.1748

Reference17 articles.

1. Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Radioembolization for hepatocellular carcinoma

3. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival

4. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

5. Analysis of Prognostic Factors After Yttrium-90 Radioembolization of Advanced Hepatocellular Carcinoma

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled;Seminars in Nuclear Medicine;2024-07

2. Influencing factors of lung shunt fraction in transarterial radioembolization treatment;Clinical and Translational Imaging;2023-10-26

3. Influencing Factors of Lung Shunt Fraction in Transarterial Radioembolization Treatment;2023-07-03

4. Recent Advances in Hepatocellular Carcinoma Treatment with Radionuclides;Pharmaceuticals;2022-10-28

5. Selective internal radiation therapy for hepatocellular carcinoma: A 15‐year multicenter Australian cohort study;Journal of Gastroenterology and Hepatology;2022-09-02